Does collagen cross linking have any effect on retinal circulation in patients with keratoconus? An optical coherence tomography angiography (OCTA) study.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
03 May 2024
Historique:
received: 31 12 2023
accepted: 26 04 2024
medline: 3 5 2024
pubmed: 3 5 2024
entrez: 2 5 2024
Statut: epublish

Résumé

We aimed to employ Optical Coherence Tomography Angiography (OCTA) to comprehensively assess changes in the optic nerve head (ONH) and macular perfusion before and after the Corneal Collagen Cross-Linking (CCL) procedure in patients with keratoconus. A total of 22 keratoconus patient's candidate for CCL procedures were included based on specific criteria, with meticulous exclusion criteria in place to minimize potential confounders. Participants underwent OCTA assessments of the ONH and macula using the Spectralis OCT (Heidelberg) before CCL, as well as at 1- and 3-months post-CCL. MATLAB software was utilized for image analysis. The mean age of the participants was 20.09 ± 6.11, including 59% male, and the mean intraocular pressure (IOP) before the surgery was 13.59 ± 2.85 mmHg. Peripapillary Retinal nerve fiber layer (ppRNFL) thickness and overall retinal thickness remained stable post-CCL. However, significant alterations were observed in macular vessel density, emphasizing regional variations in vascular response. For macular large vessel density (LVD), both superficial and deep vascular complex (SVC and DVC) demonstrated significant differences between before surgery and the 3 months post-surgery follow-up (p < 0.001 and p = 0.002, respectively). Optic nerve head markers demonstrated relative stability, except for changes in avascular complex density, which was 49.2 ± 2.2% before the surgery and decrease to 47.6 ± 1.7% three months after the operation (P-value = 0.005). While CCL appears to maintain the integrity of certain ocular structures, alterations in macular perfusion post-CCL suggest potential effects on retinal blood supply. Long-term monitoring is crucial to understand the implications of these changes, particularly in the context of conditions such as diabetes.

Sections du résumé

BACKGROUND BACKGROUND
We aimed to employ Optical Coherence Tomography Angiography (OCTA) to comprehensively assess changes in the optic nerve head (ONH) and macular perfusion before and after the Corneal Collagen Cross-Linking (CCL) procedure in patients with keratoconus.
METHODS METHODS
A total of 22 keratoconus patient's candidate for CCL procedures were included based on specific criteria, with meticulous exclusion criteria in place to minimize potential confounders. Participants underwent OCTA assessments of the ONH and macula using the Spectralis OCT (Heidelberg) before CCL, as well as at 1- and 3-months post-CCL. MATLAB software was utilized for image analysis.
RESULTS RESULTS
The mean age of the participants was 20.09 ± 6.11, including 59% male, and the mean intraocular pressure (IOP) before the surgery was 13.59 ± 2.85 mmHg. Peripapillary Retinal nerve fiber layer (ppRNFL) thickness and overall retinal thickness remained stable post-CCL. However, significant alterations were observed in macular vessel density, emphasizing regional variations in vascular response. For macular large vessel density (LVD), both superficial and deep vascular complex (SVC and DVC) demonstrated significant differences between before surgery and the 3 months post-surgery follow-up (p < 0.001 and p = 0.002, respectively). Optic nerve head markers demonstrated relative stability, except for changes in avascular complex density, which was 49.2 ± 2.2% before the surgery and decrease to 47.6 ± 1.7% three months after the operation (P-value = 0.005).
CONCLUSION CONCLUSIONS
While CCL appears to maintain the integrity of certain ocular structures, alterations in macular perfusion post-CCL suggest potential effects on retinal blood supply. Long-term monitoring is crucial to understand the implications of these changes, particularly in the context of conditions such as diabetes.

Identifiants

pubmed: 38698363
doi: 10.1186/s12886-024-03470-1
pii: 10.1186/s12886-024-03470-1
doi:

Substances chimiques

Collagen 9007-34-5
Cross-Linking Reagents 0
Photosensitizing Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

201

Informations de copyright

© 2024. The Author(s).

Références

Rabinowitz YS, Keratoconus. Surv Ophthalmol. 1998;42(4):297–319.
doi: 10.1016/S0039-6257(97)00119-7 pubmed: 9493273
Miháltz K, Kovács I, Takács A, Nagy ZZ. Evaluation of keratometric, pachymetric, and elevation parameters of keratoconic corneas with pentacam. Cornea. 2009;28(9):976–80.
doi: 10.1097/ICO.0b013e31819e34de pubmed: 19724217
Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Age-specific incidence and prevalence of Keratoconus: a Nationwide Registration Study. Am J Ophthalmol. 2017;175:169–72.
doi: 10.1016/j.ajo.2016.12.015 pubmed: 28039037
Ertan A, Colin J. Intracorneal rings for keratoconus and keratectasia. J Cataract Refract Surg. 2007;33(7):1303–14.
doi: 10.1016/j.jcrs.2007.02.048 pubmed: 17586391
Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf. 2013;11(2):65–74.
doi: 10.1016/j.jtos.2013.01.002 pubmed: 23583042
Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509–23.
doi: 10.1016/j.survophthal.2015.04.002 pubmed: 25980780
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–7.
doi: 10.1016/S0002-9394(02)02220-1 pubmed: 12719068
Farjadnia M, Naderan M. Corneal cross-linking treatment of keratoconus. Oman J Ophthalmol. 2015;8(2):86–91.
doi: 10.4103/0974-620X.159105 pubmed: 26622134 pmcid: 4640047
Mirzaei M, Bagheri M, Taheri A. Influence of standard corneal cross-linking in keratoconus patients on macular profile. J Curr Ophthalmol. 2018;30(4):330–6.
doi: 10.1016/j.joco.2018.06.003 pubmed: 30555966 pmcid: 6277222
Goldich Y, Marcovich AL, Barkana Y, Avni I, Zadok D. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea. 2010;29(4):409–11.
doi: 10.1097/ICO.0b013e3181bd9f8c pubmed: 20164744
Ham WT Jr., Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature. 1976;260(5547):153–5.
doi: 10.1038/260153a0 pubmed: 815821
Grewal DS, Brar GS, Jain R, Sood V, Singla M, Grewal SP. Corneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus: one-year analysis using Scheimpflug imaging. J Cataract Refract Surg. 2009;35(3):425–32.
doi: 10.1016/j.jcrs.2008.11.046 pubmed: 19251133
Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.
doi: 10.1016/j.ajo.2008.05.032 pubmed: 18639219
Dhawan S, Rao K, Natrajan S. Complications of corneal collagen cross-linking. J Ophthalmol. 2011;2011:869015.
doi: 10.1155/2011/869015 pubmed: 22254130 pmcid: 3255294
Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385–9.
doi: 10.1097/ICO.0b013e3180334f78 pubmed: 17457183
Bechmann M, Ehrt O, Thiel MJ, Kristin N, Ulbig MW, Kampik A. Optical coherence tomography findings in early solar retinopathy. Br J Ophthalmol. 2000;84(5):547–8.
doi: 10.1136/bjo.84.5.546b pubmed: 10847708
Nasrollahi K, Razmjoo F, Naderan M, Peyman A. Corneal cross-linking for keratoconus: evaluation of the retina and choroid. Eur J Ophthalmol. 2022;32(3):1491–5.
doi: 10.1177/11206721211021300 pubmed: 34053332
Ozsaygili C, Yildirim Y. Safety of accelerated corneal collagen cross-linking in keratoconus patients on the basis of macular segmentation. Int Ophthalmol. 2021;41(11):3759–67.
doi: 10.1007/s10792-021-01945-4 pubmed: 34247284
Barbisan PRT, Viturino MGM, Souto FMS, Tian B, Pacheco Pinto RD, Quagliato LB, et al. Macular phototoxicity after corneal cross-linking. Clin Ophthalmol. 2018;12:1801–7.
doi: 10.2147/OPTH.S176025 pubmed: 30271113 pmcid: 6147203

Auteurs

Shahram Bamdad (S)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Alireza Attar (A)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Milad Fallahzadeh (M)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Ebrahimi (F)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Sanam Faizabadi (S)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Ali Azimi (A)

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Ali.azimi1365@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH